UCART19 can bridge to transplant in adultsMarch 29, 2018Leukemia, Myelodysplasia, TransplantationTransplantationALL
Phase 1 results with UCART19 in kidsMarch 28, 2018Leukemia, Myelodysplasia, TransplantationPediatricsTransplantationALL
ICER assesses value of CAR T-cell therapiesMarch 27, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
Manufactured graft deemed safe in blood cancer patientsMarch 21, 2018AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLALLMyelodysplastic Syndrome
Metabolic changes in T cells may limit CAR potential in kidsMarch 19, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLAggressive Lymphomas
Method may predict relapse at BCP-ALL diagnosisMarch 6, 2018Leukemia, Myelodysplasia, TransplantationPediatricsALL
Expanded UCB product can stand aloneFebruary 27, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationAMLALLMyelodysplastic Syndrome
Disease burden impacts survival, toxicity after CAR T-cell therapyFebruary 8, 2018Leukemia, Myelodysplasia, TransplantationALL
Socioeconomic deprivation tied to survival in ALLFebruary 4, 2018Leukemia, Myelodysplasia, TransplantationALL
CAR T-cell therapy produces durable CRs in ALLFebruary 1, 2018Leukemia, Myelodysplasia, TransplantationALL
CAR T-cell therapy on fast track in US, EUJanuary 18, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsALLNon-Hodgkin LymphomaAggressive Lymphomas
Survival differences among AYAs with blood cancersJanuary 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Gene variants associated with high-risk pediatric ALLJanuary 10, 2018Leukemia, Myelodysplasia, TransplantationPediatricsALL
